Search Results

Oral Versus Intravenous Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients on Maintenance Hemodialysis-Effect on Fibroblast Growth Factor-23 Metabolism.

• Authors : Fukao W; Division of Kidney and Dialysis, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan; Department of Kidney and Dialysis, Meiwa Hospital, Nishinomiya, Hyogo, Japan.

Subjects: Renal Dialysis*; Anemia, Iron-Deficiency/Anemia, Iron-Deficiency/Anemia, Iron-Deficiency/*drug therapy ; Ferric Oxide, Saccharated/Ferric Oxide, Saccharated/Ferric Oxide, Saccharated/*therapeutic use

• Source: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation [J Ren Nutr] 2018 Jul; Vol. 28 (4), pp. 270-277. Date of Publisher: W.B. Saunders Co Country of Publication: United States NLM ID: 9112938 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors.

• Authors : Carullo, Nazareno; Sorbo, David; Faga, Teresa

• Source: International Journal of Molecular Sciences; Dec2024, Vol. 25 Issue 23, p12838, 21p

Record details

Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia.

• Authors : Ito K; Medical Affairs Department, Torii Pharmaceutical Co., Ltd., 3-4-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, 103-8439, Japan.; Doctoral Program in Life Science Innovation (Disease Mechanism), Degree Programs in Comprehensive Human Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8577, Japan.

Subjects: Fibroblast Growth Factors*/Fibroblast Growth Factors*/Fibroblast Growth Factors*/blood ; Ferric Compounds*/Ferric Compounds*/Ferric Compounds*/therapeutic use ; Ferric Compounds*/Ferric Compounds*/Ferric Compounds*/administration & dosage

• Source: Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Jul; Vol. 28 (7), pp. 636-646. Date of Electronic Publication: 2024 Feb 25.Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7799

Record details

Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease.

• Authors : Kassianides, Xenophon; Bhandari, Sunil

Subjects: FIBROBLAST growth factors; IRON supplements; CHRONIC kidney failure

• Source: Kidney & Blood Pressure Research; 2023, Vol. 48 Issue 1, p151-164, 14p

Record details

Markers of Oxidative Stress, Inflammation and Endothelial Function following High-Dose Intravenous Iron in Patients with Non-Dialysis-Dependent Chronic Kidney Disease—A Pooled Analysis.

• Authors : Kassianides, Xenophon; White, Steven; Bhandari, Sunil

Subjects: CHRONIC kidney failure; OXIDATIVE stress; IRON deficiency anemia

• Source: International Journal of Molecular Sciences; Dec2022, Vol. 23 Issue 24, p16016, 11p

Record details

Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.

• Authors : Biruete, Annabel; Metzger, Corinne E; Chen, Neal X

Subjects: RENAL osteodystrophy; IRON; BONE mechanics

• Source: Nephrology Dialysis Transplantation; Oct2022, Vol. 37 Issue 10, p1857-1867, 11p

Record details

Critical illness and bone metabolism: where are we now and what is next?

• Authors : Cai, Yun; Kang, Fuxin; Wang, Xiaozhi

Subjects: BONE metabolism; CRITICALLY ill; BONE health

• Source: European Journal of Medical Research; 9/14/2022, Vol. 27 Issue 1, p1-10, 10p

Record details

High-dose versus low-dose iron sucrose in individuals undergoing maintenance haemodialysis: a retrospective study.

• Authors : Liu, Luojin; Cheng, Huihui; Lv, Yukai

Subjects: HEMODIALYSIS; SUCROSE; DRUG-eluting stents

• Source: BMC Nephrology; 10/27/2021, Vol. 22 Issue 1, p1-10, 10p

Record details

Iron Infusion and Induced Hypophosphatemia: The Role of Fibroblast Growth Factor‐23.

• Authors : Coppolino, Giuseppe; Nicotera, Ramona; Cernaro, Valeria

Subjects: HYPOPHOSPHATEMIA; IRON deficiency anemia; BIOCHEMICAL mechanism of action

• Source: Therapeutic Apheresis & Dialysis; Jun2020, Vol. 24 Issue 3, p258-264, 7p

Record details

Regulation of fibroblast growth factor 23 (FGF23) in health and disease.

• Authors : Bär, Ludmilla; Stournaras, Christos; Lang, Florian

Subjects: FIBROBLAST growth factors; CALCITRIOL; CARDIOVASCULAR diseases

• Source: FEBS Letters; Aug2019, Vol. 593 Issue 15, p1879-1900, 22p

Record details